Also preserved in our archive
seen from Germany

seen from Brazil
seen from China

seen from China
seen from United Kingdom
seen from United States
seen from United Kingdom

seen from United States
seen from United States
seen from United Kingdom

seen from United States

seen from United States
seen from T1
seen from United States
seen from United States
seen from Malaysia

seen from Malaysia

seen from United States
seen from United States
seen from United Kingdom
Also preserved in our archive
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study,
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy. Treatments involving the use of the body's immune system to fight cancer have led to significant improvements in patient survival in recent years, particularly using a method called CAR T-cell therapy. This treatment involves extracting a patient's own T-cells and modifying them in a lab to express a special receptor called a Chimeric antigen receptor (CAR) that recognizes a tumor protein. These are then reinfused back into the patient, where they can find and destroy cancer cells.
Continue Reading.
Transcriptional reprogramming primes CD8+ T cells toward exhaustion in Myalgic encephalomyelitis/chronic fatigue syndrome (PDF)
Transcriptional reprogramming primes CD8+ T cells toward exhaustion in Myalgic encephalomyelitis/chronic fatigue syndrome
Significance
Myalgic encephalomyelitis/chronic fatigue syndrome (ME) is a serious disabling chronic illness that lacks FDA-approved therapies. Comprehensive transcriptomic, epigenomic, and flow cytometric profiles of primary CD8+ T cell subsets implicate T cell exhaustion in pathophysiology. We show that T cells in ME cases are epigenetically predisposed toward terminal exhaustion and that exhaustion markers are upregulated following exercise challenge. Using single-cell genomics, we provide important information about the role of CD8+ T cell exhaustion development and progression. Our findings are consistent with the hypothesis that chronic viral infection is a factor in ME; by dissecting the molecular basis of T cell dysfunction in ME, we offer potential avenues for treatment.
Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back
Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune system. It esse
Attacks Evaders
Cancer cells are masters of evasion, finding innovative ways to survive treatments. Researchers now investigate why tumours return after immunotherapy, a treatment using the immune system’s killer T-cells which appear to effectively target and then kill cancer cells by injecting them with toxic granules. In a mouse cancer model, where tumours have returned after initial immunotherapy, scanning electron microscopy revealed that cancer cells hid within each other – a process called cell-in-cell formation – to avoid destruction. Exposing cancer cells from the tumours, to different immune cells in a dish revealed that killer T-cells specifically triggered cell-in-cell formation, as captured here using live-cell imaging. Injecting mice with drugs that blocked a molecular pathway activated by the killer T-cell attack before cell-in-cell formation, increased the effectiveness of subsequent immunotherapy. This reveals an important cancer mechanism for evading immunotherapy and a starting point to counter it.
Written by Lux Fatimathas
Video from work by Amit Gutwillig and colleagues
Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Video originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)
Published in eLife, September 2022
You can also follow BPoD on Instagram, Twitter and Facebook
Monash Biomedicine Develops New Approach for Bolstering T-Cells Ability to Fight Cancer
Credit: CC0 Public Domain A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer therapy The study shows that by inhibiting the protein tyrosine phosphatase PTP1B in T cells, the body’s immune response to cancer can be mobilized, helping to repress tumor growth. T cells are an essential part of the…
View On WordPress
T-Killer Bakugou
T-Killer has so many expressions fitting Bakugou!!! I wanted to draw a lot of them XD But for now I did only this one.
“Genesis” (S07E019, Stardate 47653.2) is a filler episode. There are no ethical or moral debates to be found, no great character growth to be discovered and no undiscovered family members to meet. There is just a crazy sci-fi concept to run with and if you buy in it can be fun. For this poster I went for a horror poster vibe and even included some simple T-cells for added flair.